2 No-Brainer Healthcare Stocks to Buy Now
Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…
Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
One of the most compelling acquisition sagas in the pharma industry in recent times has come to an…
Why Weight-Loss Drug Prices Are Falling| Business News
President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
Trump seeks lower prices for Wegovy, Zepbound
President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
5 Things Retirees Need To Know About the New Trump Drug Program
The Trump administration and Pfizer have made an agreement for the drug company to sell many medications to…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
Here Are 2 With Even More Upside Ahead
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to…
What is TrumpRx? All about direct-to-consumer website for discounted drug purchases – News
Though the complete operational specifics of TrumpRx are not yet available, the government and parties involved have made…
What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…